Skip to main content

Cardiology Update London 2026

-
City
London, UK
Type of event
on site

Welcome Address

Dear Colleagues

It is a real pleasure to announce the 10th Christmas Postgraduate Course of the Guys and St. Thomas’ NHS Foundation Trust & Imperial College, the Cardiology Update London.

Cardiology and cardiovascular medicine in general is a rapidly expanding field with impressive developments and innovations over the last years. For physicians, be it general practitioners, cardiologists or cardiac surgeons, it is therefore important to keep pace with a challenging environment. To that end, we have designed a postgraduate course, the Cardiology Update London, to summarize, at the end of the year, the most important new developments, innovations, but also failures that will all affect cardiovascular diagnosis and management in our everyday practice.

We have selected an international Faculty of high standing experts both from the Trust and worldwide, covering the broad spectrum of cardiovascular medicine from prevention to intervention, from valvular heart disease to heart failure, and from conservative management to intervention and surgical operations. Thus, the course will give an up-to-date overview about current diagnosis and management of the most important cardiovascular conditions during two days in London.

We would be most happy to welcome you at the Hallam Conference Center in central London to enjoy two days of interactive education for the benefit of your practice and your patients.

Yours sincerely,

Prof. Thomas F. Lüscher
MD, FRPC, FESC

Prof. Peter Libby
FESC, FACC

Prof. Bernard J. Gersh   
FACC

Dr. Richard Grocott-Mason
MD, FRCP

Dr. Eleanor Wicks
FESC


Program Overview

Monday , December 14th(UK Time)Tuesday, December 15th (UK Time)
8:30Welcome Address
Opening Lectures
8:30

Session 4
ACS and Cardiogenic Shock

  • Long term results of SCOT-Heart
  • MINOCA revisited
  • Aspirin and Clopidogrel after PCI
  • Cardiogenic shock since DANGER
     
9:45Coffee break10:15Coffee break
10:15

Session 1
Risk Factors and Prevention

  • PCSK9 inhibition for LDL-C reduction
  • Inflammation
  • Lp(a)
  • HORIZON Trial
  • Obesity
  • Vaccination
     
11:15

Session 5
Valvular Heart Disease

  • 2025 ESC Guidelines update
  • Biomarkers on TAVI predict outcomes
  • Tricuspid TEER vs. percutaneous valve implantation
  • Medical treatment before and after valvular interventions
12:15Industry Sponsored Session12:15Industry Sponsored Session
13:00Lunch break13:00Lunch break
14:00

Session 2
Essentials of the 2026 ESC Guidelines

  • CVD and CKD
  • Heart Failure
  • Cardiac Rehabilitation
  • Balloon angioplasty on chronic thromboembolic pulmonary hypertension
     

 

14:00

14:30

 

 

 

 

 

The Paul Hamilton Wood Lecture

Session 6
Atrial Fibrillation and HF

  • How to ablate atrial fibrillation
  • Prevention of stroke
  • The twin epidemics of atrial fibrillation and HFpEF
  • Heart failure management with AI
     

 

15:30Industry Sponsored Session  
16:00Coffee break16:15Coffee break
16:30

Session 3
AI in Cardiovascular Medicine

  • AI-enhanced stethoscope
  • AI and the ECG
  • Cardiovascular imaging by AI
  • Diagnosing cardiovascular disease with AI

 

16:45

Session 7
Myocardial & Pericardial Diseases

  • Inflammatory Myopericardial Syndrome (IMPS)
  • Myosin inhibitors in HCM
  • Cardiac amyloidosis update
  • Catheter-based management of pulmonary embolism
18:30End of day 118:15Adjourn

 

Scientific Program

Monday, December 14th, 2026 (UK time)

Venue: Hallam Conference Center

08:30 | Welcome Address 
08:30Welcome by the ESC PresidentThomas F. Lüscher, London

 

08:45 | Opening Lectures: Frontiers in Cardiovascular Science
Chairs: Peter Libby, Boston and Bernard J. Gersh, Rochester MN
08:45Opening Lectures 1 - What is the cardiologist of tomorrow?Thomas F. Lüscher, London
09:15Opening Lecture 2 - From population to person: The new era of cardiovascular prevention John E. Deanfield, London
09:45- 10:15 | Coffee Break 

 

10:15 | Session 1: Risk Factors and Prevention
Chairs: Børge Nordestgaard Copenhagen and Richard Grocott-Mason
10:15PCSK9 inhibition for LDL-C reduction: Injection or pills?Alberico Catapano, Milan
10:35Inflammation as a therapeutic target: Ready for primetime?Peter Libby, Boston
10:55Lp(a): Current status and future perspectiveBørge Nordestgaard Copenhagen
11:15Obesity and cardiometabolic risk: Integrins and their
effect on outcome
John E. Deanfield, London
11:35Vaccination as a new form of cardiovascular preventionBettina Heidecker, Berlin
11:55Panel DiscussionAll speakers from the session

 

12:15 - 13:00 | Industry-Sponsored Symposium
13:00-14:00 | Lunch Buffet

 

14:00 | Session 2: Essentials of the 2026 ESC Guidelines
Chairs: Marianna Adamo, Brescia and Irene Lang, Vienna
14:00The 2026 ESC Guidelines on CVD and CKDWilliam Herrington, London
14:20The 2026 ESC Guidelines on heart failure Marianna Adamo, Brescia
14:40The 2026 ESC Guidelines on cardiac rehabilitation Maria Bäck, Linköping
15:00Balloon angioplasty on chronic thromboembolic
pulmonary hypertension
Irene Lang, Vienna
15:20Panel DiscussionAll speakers from the session

 

15:30 - 16:00 | Industry-Sponsored Symposium
16:00-16:30 | Coffee Break

 

16:15 | Session 3: AI in Cardiovascular Medicine
Chairs: Paul Friedman, Rochester MN and Nicholas S. Peters, London
16:30The AI-enhanced stethoscopeNicholas S. Peters, London
16:50AI and the ECG: Deep insight into CVD conditions Paul Friedman, Rochester MN
17:10Transformation of cardiovascular imaging by AI Paul Leeson, Oxford
17:30Predicting outcome with AISimon Kraler, Berne
17:50Diagnosing cardiovascular disease with AIAlexander V. Eriksen, Odense
18:10Panel discussion    All speakers from the session
18:30End of Day 1 

Tuesday, December 15th, 2026 (UK Time)

Venue: Hallam Conference Center

08:30 | Session 4: Acute Coronary Syndromes and Cardiogenic Shock
Chairs: Michelle C. Williams, Edinburgh and Christian Hassager, Copenhagen
08:30CT to guide management of angina: Long term results of
SCOT-Heart 
Michelle C. Williams, Edinburgh
08:50MINOCA revisited: From necrosis to injury Chiara Bucciarelli Ducci, London
09:10Aspirin and Clopidogrel: Both or alone after PCIGilles Montalescot, Paris
09:30Cardiogenic shock: What have we learned since DANGERChristian Hassager, Copenhagen
09:50Panel discussionAll speakers from the session
   
10:15-10:45 | Coffee Break 

 

10:45 | Session 5: Valvular Heart Disease
Chairs: Simon Davies, London and Marco Metra, Milan
10:452025 ESC Guidelines on Valvular Heart Disease and beyondPhilipp Lurz, Mainz
11:05From ACS to Valves: Precision Medicine through Biomarkers
and AI
Florian Wenzl, Zurich
11:25Tricuspid TEER or percutaneous valve implantation?Francesco Maisano, Milan
11:45Medical treatment before and after valvular interventionsMarco Metra, Milan
12:05Panel discussionAll speakers from the session
12:15 - 13:00 | Industry-Sponsored Symposium
13:00-14:00 | Lunch Buffet

 

14:00 | The Paul Hamilton Wood Lecture
Chairs: Ulf Landmesser, Berlin and Peter Libby, Boston
14:00AI in cardiologyPaul Friedman, Rochester MN

 

14:30 | Session 6: Atrial Fibrillation and Heart Failure 
Chairs: Bernard J. Gersh, Rochester MN and Ulf Landmesser, Berlin
14:30How to ablate atrial fibrillation: Pulse field ablation, cooling or burning?    Shouvik Haldar, London
14:50Prevention of stroke: Anti-coagulation or left atrial appendix occlusion? Ulf Landmesser, Berlin
15:10The twin epidemics of atrial fibrillation and HFpEFBernard J. Gersh, Rochester MN
15:30Improved heart failure management with a virtual assistantDiana Gorog, London
15:50Panel discussionAll speakers from the session
16:15 - 16:45 | Coffee Break 

 

16:45 | Session 7: Myocardial & Pericardial Diseases
Chairs: Bernard J. Gersh, Rochester MN and Theresa McDonagh, London
16:45Inflammatory Myopericardial Syndrome (IMPS): A basis for precision medicineMassimo Imazio, Udine
17:05Myosin inhibitors in HCMIacopo Olivotto, Florence
17:25Cardiac amyloidosis: An update Peter van der Meer, Groningen
17:45Catheter-based management of pulmonary embolism: Technique and outcomes Stavros Konstantinides, Mainz
18:05Panel discussionAll speakers from the session
   
18:15Wrap-up and AdjournThomas F. Lüscher, London

The programme is subject to change

General Information

Registration

Registrations can be made exclusively online on our website: www.cardiologyupdate.uk

Category 
Registration fees 
Regular feeGBP 300
Early registration fee (until November 13, 2026)GBP 250
  
Trainees/Residents, Research fellows, Nurses, Students <40 years (ID proof required)* 
Regular feeGBP 150
Early registration fee (until November 13, 2026)GBP 100
Day TicketGBP 150
  
Group Registration (For group registrations a minimum of 10 participants is required)** 
Regular feeGBP 260
Early registration fee (until November 13, 2026)GBP 210

*For the reduced registration (Trainees/Residents, Research fellows, Nurses, Students <40 years) please send a copy of your ID to Ms. Nadine-Estelle Abea at nadine-estelle.abea@zhh.ch.

**Please contact Ms. Nadine-Estelle Abea (nadine-estelle.abea@zhh.ch) at the Zurich Heart House to obtain further information.

Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.

Modification & Cancellation

All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to the Zurich Heart House. For each modification requested by the participant, GBP 50 will be charged for administrative costs. In case of cancellation up to 1st of November 2026, deposits will be refunded less 35 % for administrative costs. After this date, no refund will be possible.

Travel to London - Electronic travel authorisation (ETA) 

From 2 April 2025, EU citizens will require an Electronic Travel Authorisation (ETA) to enter the UK. For non-EU citizens, the regulation will come into force on 8 January 2025. More information can be found on https://www.gov.uk/guidance/apply-for-an-electronic-travel-authorisation-eta. It will be possible to apply for the ETA, which will be required from April, from 5 March 2025 onwards. For nationals of certain countries outside Europe, the ETA will be required from 8 January 2025. The application is again possible from 27 November 2024: https://www.gov.uk/guidance/check-when-you-can-get-an-electronic-travel-authorisation-eta. You won’t have to apply in case you have a VISA.

Venue

Hallam Conference Center
44 Hallam St, London W1W 6JJ, United Kingdom

Organisation

Zurich Heart House, Foundation for Cardiovascular Research
Dr. Eleanor Wicks
Nadine-Estelle Abea
Charlesworth House, 48 Stanhope Gardens, London SW7 5RD
Phone +41 (0) 44 250 40 95


Accreditation

The Cardiology Update London has been submitted to:

  • Federation of the Royal Colleges of Physicians of the
    United Kingdom for CPD credits
  • EACCME-UEMS
    European Accreditation Council for Continuing Medical
    Education (EACCME®)
  • British Cardiovascular Society
     


In collaboration with

Under the auspices of

Register here

Anmeldeschluss